Pharmacokinetic (PK) Reports for Clinical Trials
Pharmacokinetic Reports in Clinical Trials?
Pharmacokinetic (PK) reports are produced to describe the results of pharmacokinetic studies. Pharmacokinetic studies are conducted to evaluate the absorption, distribution, metabolism, and excretion of a drug under investigation. Compounds with good PK results are more likely to be effective and safe. Then, preclinical and early-stage clinical PK evaluations should ensure that new drug candidates have optimal profiles to advance into the clinic.
Sofpromed’s Biostatistics and Statistical Programming Services
Sofpromed is a clinical research organization (CRO) specialized in providing biostatistics and statistical programming services, including SAS programming. Our statistical capabilities include:
- Sample size calculation
- Statistical analysis plans (SAPs)
- SAS programming
- Statistical reports
- Pharmacokinetics (PKs) reports
Sofpromed’s statistical services are offered for phase I-IV clinical trials and post-approval studies in a wide variety of therapeutic areas such as oncology, cardiovascular, metabolic, central nervous system, dermatology, infectious, and respiratory diseases, among others.